Skip to main content
SpringerLink
Log in

Membrane-Type Matrix Metalloproteinases

  • Chapter
Proteases and Their Inhibitors in Cancer Metastasis

Part of the book series: Cancer Metastasis — Biology and Treatment ((CMBT,volume 4))

  • 111 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Afzal S, Lalani EN, Poulsom R, Stubbs A, Rowlinson G, Sato H, Seiki M, Stamp GW. MT1-MMP and MMP-2 mRNA expression in human ovarian tumors: possible implications for the role of desmoplastic fibroblasts. Hum Pathol 1998; 29: 155–165.

    Article  CAS  PubMed  Google Scholar 

  • Apte SS, Fukai N, Beier DR, Olsen BR. The matrix metalloproteinase-14 (MMP-14). gene is structurally distinct from other MMP genes and Is Co-expressed with the TIMP-2 gene during mouse embryogenesis, J Biol Chem 1997; 272: 25511–25517.

    Article  CAS  PubMed  Google Scholar 

  • Brooks PC, Silletti S. von T, Friedlander M, Cheresh DA. Disruption of angiogenesis by PEX, a non-catalytic metalloproteinase fragment with integrin binding activity. Cell 1998; 92: 391–400.

    Article  CAS  PubMed  Google Scholar 

  • Butler GS, Butler MJ, Atkinson SJ, Will H, Tamura T, van Westrum SS, Crabbe T, Clements J, Pia ďOrtho M, Murphy G. The TIMP2 membrane type 1 metalloproteinase ‘receptor’ regulates the concentration and efficient activation of progelatinase A. A kinetic study. J Biol Chem 1998; 273: 871–880.

    Article  CAS  PubMed  Google Scholar 

  • Cao J, Sato H, Takino T, Seiki M. The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for pro-gelatinase A activation. J Biol Chem 1995: in press.

    Google Scholar 

  • Cao J, Rehemtulla A, Bahou W, Zucker S. Membrane type matrix metalloproteinase 1 activates pro-gelatinase A without furin cleavage of the N-terminal domain. J Biol Chem 1996; 271: 30174–30180.

    Article  CAS  PubMed  Google Scholar 

  • Chenard MP, Lutz Y, Mechine-Neuville A, Stoll I, Bellocq JP, Rio MC, Basset P. Presence of high levels of MT1-MMP protein in fibroblastic cells of human invasive carcinomas. Int J Cancer 1999; 82: 208–812.

    Article  CAS  PubMed  Google Scholar 

  • Cowell S, Knauper V, Stewart ML, D’Ortho MP, Stanton H, Hembry RM, Lopez-Otin C, Reynolds JJ, Murphy G. Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: associated activation of gelatinase A, gelatinase B and collagenase 3. Biochem J 1998; 331: 453–458.

    CAS  PubMed  Google Scholar 

  • ďOrtho MP, Will H, Atkinson S, Butler G, Messent A, Gavrilovic J, Smith B, Timpl R, Zardi L, Murphy G. Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur J Biochem 1997; 250: 751–757.

    Article  Google Scholar 

  • English WR, Puente XS, Freije JM, Knauper V, Amour A, Merryweather A, Lopez-Otin C, Murphy G. Membrane type 4 matrix metalloproteinase (MMP17) has tumor necrosis factor-alpha convertase activity but does not activate pro-MMP2. J Biol Chem 2000; 275: 14046–14055.

    Article  CAS  PubMed  Google Scholar 

  • Fishman DA, Bafetti LM, Stack MS. Membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation in primary human ovarian epithelial carcinoma cells. Invasion Metastasis 1996; 16: 150–159.

    CAS  PubMed  Google Scholar 

  • Forsyth PA, Wong H, Laing TD, Rewcastle NB, Morris DG, Muzik H, Leco KJ, Johnston RN, Brasher PM, Sutherland G, Edwards DR. Gelatinase-A (MMP-2). gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas. Br J Cancer 1999; 79: 1828–1835.

    Article  CAS  PubMed  Google Scholar 

  • Fosang AJ, Last K, Fujii Y, Seiki M, Okada Y. Membrane-type 1 MMP (MMP-14) cleaves at three sites in the aggrecan interglobular domain. FEBS Lett 1998; 430: 186–190.

    Article  CAS  PubMed  Google Scholar 

  • Giannelli G, Falk-Marzillier J, Schiraldi O, Stetler-Stevenson WG, Quaranta V. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science 1997; 277: 225–228.

    Article  CAS  PubMed  Google Scholar 

  • Gilles C, Polette M, Piette J, Munaut C, Thompson EW, Birembaut P, Foidart JM. High level of MT-MMP expression is associated with invasiveness of cervical cancer cells. Int J Cancer 1996; 65: 209–213.

    Article  CAS  PubMed  Google Scholar 

  • Haas TL, Stitelman D, Davis SJ, Apte SS, Madri JA. Egr-1 mediates extracellular matrix-driven transcription of membrane type 1 matrix metalloproteinase in endothelium. J Biol Chem 1999; 274: 22679–22685.

    Article  CAS  PubMed  Google Scholar 

  • Harada T, Arii S, Mise M, Imamura T, Higashitsuji H, Furutani M, Niwano M, Ishigami S, Fukumoto M, Seiki M, Sato H, Imamura M. Membrane-type matrix metalloproteinase-1 (MT1-MTP) gene is over-expressed in highly invasive hepatocellular carcinomas. J Hepatol 1998; 28: 231–239.

    Article  CAS  PubMed  Google Scholar 

  • Heppner KJ, Matrisian LM, Jensen RA, Rodgers WH. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol 1996; 149: 273–282.

    CAS  PubMed  Google Scholar 

  • Hiraoka N, Allen E, Apel IJ, Gyetko MR, Weiss SJ. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell 1998; 95: 365–377.

    Article  CAS  PubMed  Google Scholar 

  • Holmbeck K, Bianco P, Caterina J, Yamada S, Kromer M, Kuznetsov SA, Mankani M, Robey PG, Poole AR, Pidoux I, Ward J M, Birkedal-Hansen H. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 1999; 99: 81–92.

    Article  CAS  PubMed  Google Scholar 

  • Hosaka M, Nagahama M, Kim WS, Watanabe T, Hatsuzawa K, Ikemizu J, Murakami K, Nakayama K. Arg-X-Lys/Arg-Arg motif as a signal for precursor cleavage catalyzed by furin within the constitutive secretory pathway. J Biol Chem 1991; 266; 12127–12130.

    CAS  PubMed  Google Scholar 

  • Hotary K, Allen E, Punturieri A, Yana I, Weiss SJ. Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J Cell Biol 2000; 149: 1309–1323.

    Article  CAS  PubMed  Google Scholar 

  • Imai K, Ohuchi E, Aoki T, Nomura H, Fujii Y, Sato H, Seiki M, Okada Y. Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metallo-proteinases 2. Cancer Res 1996; 56: 2707–2710.

    CAS  PubMed  Google Scholar 

  • Ishigaki S, Toi M, Ueno T, Matsumoto H, Muta M, Koike M, Seiki M. Significance of membrane type 1 matrix metalloproteinase expression in breast cancer. Jpn J Cancer Res 1999; 90: 516–522.

    CAS  PubMed  Google Scholar 

  • Itoh T, Tanioka M, Yoshida H, Yoshioka T, Nishimoto H, Itohara S. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res 1998; 58: 1048–1051.

    CAS  PubMed  Google Scholar 

  • Itoh Y, Kajita M, Kinoh H, Mori H, Okada A, Seiki M. Membrane type 4 matrix metalloproteinase (MT4-MMP, MMP-17) is a glycosylphosphatidylinositol-anchored proteinase. J Biol Chem 1999; 274: 34260–34266.

    Article  CAS  PubMed  Google Scholar 

  • Kadono Y, Shibahara K, Namiki M, Watanabe Y, Seiki M, Sato H. Membrane type 1-matrix metalloproteinase is involved in the formation of hepatocyte growth factor/scatter factor-induced branching tubules in madin-darby canine kidney epithelial cells. Biochem Biophys Res Commun 1998; 251: 681–687.

    Article  CAS  PubMed  Google Scholar 

  • Kajita M, Kinoh H, Ito N, Takamura A, Itoh Y, Okada A, Sato H, Seiki M. Human membrane type-4 matrix metalloproteinase (MT4-MMP) is encoded by a novel major transcript: isolation of complementary DNA clones for human and mouse mt4-mmp transcripts. FEBS Lett 1999; 457: 353–356.

    Article  CAS  PubMed  Google Scholar 

  • Kanayama H, Yokota K, Kurokawa Y, Murakami Y, Nishitani M, Kagawa S. Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer. Cancer 1998; 82: 1359–1366.

    Article  CAS  PubMed  Google Scholar 

  • Kinoh H, Sato H, Tsunezuka Y, Takino T, Kawashima A, Okada Y, Seiki M. MT-MMP, the cell surface activator of proMMP-2 (pro-gelatinase A) is expressed with its substrate in mouse tissue during embryogenesis. J Cell Sci 1996: 953–959.

    Google Scholar 

  • Kinoshita T, Sato H, Okada A, Ohuchi E, Imai K, Okada Y, Seiki M. TIMP-2 promotes activation of progelatinase A by membrane-type 1 matrix metalloproteinase immobilized on agarose beads. J Biol Chem 1998; 273: 16098–16103.

    Article  CAS  PubMed  Google Scholar 

  • Kitagawa Y, Kunimi K, Ito H, Sato H, Uchibayashi T, Okada Y, Seiki M, Namiki M. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human urothelial carcinomas. J Urol 1998; 160: 1540–1545.

    Article  CAS  PubMed  Google Scholar 

  • Knauper V, Lopez-Otin C, Smith B, Knight G, Murphy G. Biochemical characterization of human collagenase-3. J Biol Chem 1996; 271: 1544–1550.

    Article  CAS  PubMed  Google Scholar 

  • Knauper V, Will H, Lopez OC, Smith B, Atkinson SJ, Stanton H, Hembry RM, Murphy G. Cellular mechanisms for human procollagenase-3 (MMP-13) activation Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme. J Biol Chem 1996; 271: 17124–17131.

    Article  CAS  PubMed  Google Scholar 

  • Kojima S, Itoh Y, Matsumoto S, Masuho Y, Seiki, M. Membrane-type 6 matrix metalloproteinase (MT6-MMP, MMP-25) is the second glycosyl-phosphatidyl inositol (GPI)-anchored MMP. FEBS Lett 2000: in press.

    Google Scholar 

  • Kolkenbrock H, Essers L, Ulbrich N, Will H. Biochemical characterization of the catalytic domain of membrane-type 4 matrix metalloproteinase. Biol Chem 1999; 380: 1103–1108.

    Article  CAS  PubMed  Google Scholar 

  • Koshikawa N, Giannelli G, Cirulli V, Miyazaki K, Quaranta V. Role of cell surface metallprotease MT1-MMP in epithelial cell migration over laminin-5. J Cell Biol 2000; 148: 615–624.

    Article  CAS  PubMed  Google Scholar 

  • Lehti K, Lohi J, Valtanen H, Keski-Oja J. Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface, Biochem J 1998; 334, 345-353.

    Google Scholar 

  • Llano E, Pendas AM, Freije JP, Nakano A, Knauper V, Murphy G, Lopez-Otin C. Identification and characterization of human MT5-MMP, a new membrane-bound activator of progelatinase a overexpressed in brain tumors. Cancer Res 1999; 59: 2570–2576.

    CAS  PubMed  Google Scholar 

  • Lohi J, Lehti K, Valtanen H, Parks WC, Keski-Oja J. Structural analysis and promoter characterization of the human membrane-type matrix metalloproteinase-1 (MT1-MMP) gene. Gene 2000; 242: 75–86.

    Article  CAS  PubMed  Google Scholar 

  • Maquoi E, Frankenne F, Baramova E, Munaut C, Sounni NE, Remacle A, Noel A, Murphy G, Foidart JM. Membrane type 1 matrix metalloproteinase-associated degradation of tissue inhibitor of metalloproteinase 2 in human tumor cell lines. J Biol Chem 2000; 275: 11368–11378.

    Article  CAS  PubMed  Google Scholar 

  • Matsumoto S, Katoh M, Saito S, Watanabe T, Masuho Y. Identification of soluble type of membrane-type matrix metalloproteinase-3 formed by alternatively spliced mRNA. Biochim Biophys Acta 1997; 1354: 159–170.

    CAS  PubMed  Google Scholar 

  • McCawley LJ, Matrisian LM. Matrix metalloproteinases: multifunctional contributors to tumor progression. Mol Med Today 2000; 6: 149–156.

    Article  CAS  PubMed  Google Scholar 

  • Monsky WL, Kelly T, Lin C-Y, Yeh Y, Stetler-Stevenson WG, Mueller SC, Chen W-T. Binding and localization of Mr 72,000 matrix metalloproteinase at cell surface invadopondia. Cancer Res 1993; 53: 3159–3164.

    CAS  PubMed  Google Scholar 

  • Mori M, Mimori K, Shiraishi T, Fujie T, Baba K, Kusumoto H, Haraguchi M, Ueo H, Akiyoshi T. Analysis of MT1-MMP and MMP2 expression in human gastric cancers. Int J Cancer 1997; 74: 316–321.

    Article  CAS  PubMed  Google Scholar 

  • Murphy G, Gavrilovic J. Proteolysis and cell migration: creating a path? Curr Opin Cell Biol 1999; 11: 614–621.

    Article  CAS  PubMed  Google Scholar 

  • Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem 1999; 274: 21491–21494.

    Article  CAS  PubMed  Google Scholar 

  • Nakada M, Nakamura H, Ikeda E, Fujimoto N, Yamashita J, Sato H, Seiki M, Okada Y. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors. Am J Pathol 1999; 154: 417–428.

    Article  CAS  PubMed  Google Scholar 

  • Nakahara H, Howard L, Thompson EW, Sato H, Seiki M, Yeh Y, Chen WT. Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion. Proc Natl Acad Sci (USA) 1997; 94: 7959–7964.

    Article  CAS  ADS  Google Scholar 

  • Nakamura H, Ueno H, Yamashita K, Shimada T, Yamamoto E, Noguchi M, Fujimoto N, Sato H, Seiki M, Okada Y. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas. Cancer Res 1999; 59: 467–473.

    CAS  PubMed  Google Scholar 

  • Nawrocki B, Polette M, Marchand V, Monteau M, Gillery P, Tournier JM, Birembaut P. Expression of matrix metalloproteinases and their inhibitors in human bronchopulmonary carcinomas: quantificative and morphological analyses. Int J Cancer 1997; 72: 556–564.

    Article  CAS  PubMed  Google Scholar 

  • Nomura H, Sato H, Seiki M, Mai M, Okada Y. Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. Cancer Research 1995; 55: 3263–3266.

    CAS  PubMed  Google Scholar 

  • Ohtani H, Motohashi H, Sato H, Seiki M, Nagura H. Dual over-expression pattern of membrane-type metalloproteinase-1 in cancer and stromal cells in human gastrointestinal carcinoma revealed by in situ hybridization and immunoelectron microscopy. Int J Cancer 1996; 68: 565–570.

    Article  CAS  PubMed  Google Scholar 

  • Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 1997; 272: 2446–2451.

    Article  CAS  PubMed  Google Scholar 

  • Okada A, Bellocq JP, Rouyer N, Chenard MP, Rio MC, Chambon P, Basset P. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc Natl Acad Sci (USA) 1995; 92: 2730–2734.

    Article  CAS  ADS  Google Scholar 

  • Okada A, Tomasetto C, Lutz Y, Bellocq JP, Rio MC, Basset P. Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A. J Cell Biol 1997; 137: 67–77.

    Article  CAS  PubMed  Google Scholar 

  • Ota K, Stetler-Stevenson WG, Yang Q, Kumar A, Wada J, Kashihara N, Wallner EI, Kanwar YS. Cloning of murine membrane-type-1-matrix metalloproteinase (MT-1-MMP) and its metanephric developmental regulation with respect to MMP-2 and its inhibitor. Kidney Int 1998; 54: 131–142.

    CAS  PubMed  Google Scholar 

  • Pei D, Weiss SJ. Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity. J Biol Chem 1996: 271; 9135–9140.

    Article  CAS  PubMed  Google Scholar 

  • Pei D. Leukolysin/MMP25/MT6-MMP: a novel matrix metalloproteinase specifically expressed in the leukocyte lineage. Cell Res 1999; 9: 291–303.

    Article  CAS  PubMed  MathSciNet  Google Scholar 

  • Polette M, Nawrocki B, Gilles C, Sato H, Seiki M, Tournier JM, Birembaut P. MT-MMP expression and localisation in human lung and breast cancers. Virchows Arch 1996; 428: 29–35.

    Article  CAS  PubMed  Google Scholar 

  • Puente XS, Pendas AM, Llano E, Velasco G, Lopez OC. Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma. Cancer Res 1996; 56: 944–949.

    CAS  PubMed  Google Scholar 

  • Pulyaeva H, Bueno J, Polette M, Birembaut P, Sato H, Seiki M, Thompson EW. MT1-MMP correlates with MMP-2 activation potential seen after epithelial to mesenchymal transition in human breast carcinoma cells. Clin Exp Metastasis 1997; 15: 111–120.

    Article  CAS  PubMed  Google Scholar 

  • Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M (1994) A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370, 61–65.

    Article  CAS  ADS  PubMed  Google Scholar 

  • Sato H, Kinoshita T, Takino T, Nakayama K, Seiki M. Activation of a recombinant membrane type 1 matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP-2). FEBS Lett 1996; 393: 101–104.

    Article  CAS  PubMed  Google Scholar 

  • Seiki M. Membrane-type matrix metalloproteinases. Apmis 1999; 107: 137–143.

    Article  CAS  PubMed  Google Scholar 

  • Stanton H, Gavrilovic J, Atkinson SJ, ďOrtho MP, Yamada KM, Zardi L, Murphy G. The activation of ProMMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MT1-MMP (MMP-14) to a 45 kDa form. J Cell Sci 1998; 111: 2789–2798.

    CAS  PubMed  Google Scholar 

  • Stetler-Stevenson WG, Liotta LA, Kleiner DJ. Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J 1993; 7: 1434–1441.

    CAS  PubMed  Google Scholar 

  • Strongin AY, Marmer BL, Grant GA, Goldberg GI. Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2. J Biol Chem 1993; 268: 14033–14039.

    CAS  PubMed  Google Scholar 

  • Strongin, AY, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg GI. Mechanism of cell surface activation of 72-kDa type IV collagenase — Isolation of the activated form of the membrane metalloprotease. J Biol Chem 1995; 270: 5331–5338.

    Article  CAS  PubMed  Google Scholar 

  • Tokuraku M, Sato H, Murakami S, Okada Y, Watanabe Y, Seiki M. Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis. Int J Cancer 1995; 64: 355–359.

    Article  CAS  PubMed  Google Scholar 

  • Tsunezuka Y, Kinoh H, Takino T, Watanabe Y, Okada Y, Shinagawa A, Sato H, Seiki M. Expression of membrane-type matrix metalloproteinase 1 (MT1-MMP) in tumor cells enhances pulmonary metastasis in an experimental metastasis assay, Cancer Res 1996; 56: 5678–5683.

    CAS  PubMed  Google Scholar 

  • Ueno H, Nakamura H, Inoue M, Imai K, Noguchi M, Sato H, Seiki M, Okada Y. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Cancer Res 1997; 57: 2055–2060.

    CAS  PubMed  Google Scholar 

  • Velasco G, Cal S, Merlos-Suarez A, Ferrando AA, Alvarez S, Nakano A, Arribas J, Lopez-Otin C. Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors. Cancer Res 2000; 60: 877–882.

    CAS  PubMed  Google Scholar 

  • Wang X, Yi J, Lei J, Pei D. Expression, purification and characterization of recombinant mouse MT5-MMP protein products. FEBS Lett 1999; 462: 261–266.

    Article  CAS  PubMed  Google Scholar 

  • Wang Y, Johnson AR, Ye QZ, Dyer RD. Catalytic activities and substrate specificity of the human membrane type 4 matrix metalloproteinase catalytic domain. J Biol Chem 1999; 274: 33043–33049.

    Article  CAS  PubMed  Google Scholar 

  • Werb Z. ECM and cell surface proteolysis: regulating cellular ecology. Cell 1997; 91: 439–442.

    Article  CAS  PubMed  Google Scholar 

  • Yamamoto M, Mohanam S, Sawaya R, Fuller GN, Seiki M, Sato H, Gokaslan ZL, Liotta LA, Nicolson GL, Rao JS. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Cancer Res 1996; 56: 384–392.

    CAS  PubMed  Google Scholar 

  • Yana I, Weiss SJ. Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases. Mol Biol Cell 2000; 11: 2387–2401.

    CAS  PubMed  Google Scholar 

  • Yoshizaki, T Sato H, Maruyama Y, Murono S, Furukawa M, Park CS, Seiki M. Increased expression of membrane type 1-matrix metalloproteinase in head and neck carcinoma. Cancer 1997; 79: 139–144.

    Article  CAS  PubMed  Google Scholar 

  • Zhou Z, Apte SS, Soininen R, Cao R, Baaklini GY, Rauser RW, Wang J, Cao Y, Tryggvason K. Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc Natl Acad Sci (USA) 2000; 97: 4052–4057.

    Article  CAS  ADS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cancer Cell Research, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokane-dai, Minato-ku, Tokyo, 108-8639, Japan

    Yoshifumi Itoh & Motoharu Seiki

Authors
  1. Yoshifumi Itoh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Motoharu Seiki
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Laboratoire de Biologie des Tumeurs et du Développement, Faculté de Médecine Université de Liège, Belgium

    Jean-Michel Foidart

  2. Department of Pathology & Laboratory Medicine, University of Pennsylvania, USA

    Ruth J. Muschel

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Kluwer Academic Publishers

About this chapter

Cite this chapter

Itoh, Y., Seiki, M. (2002). Membrane-Type Matrix Metalloproteinases. In: Foidart, JM., Muschel, R.J. (eds) Proteases and Their Inhibitors in Cancer Metastasis. Cancer Metastasis — Biology and Treatment, vol 4. Springer, Dordrecht. https://doi.org/10.1007/1-4020-2008-2_6

Download citation

  • DOI: https://doi.org/10.1007/1-4020-2008-2_6

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-1-4020-0923-5

  • Online ISBN: 978-1-4020-2008-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation